Poulvac E. coli
Escherichia coli aroA gene deleted, type O78, strain EC34195 (live)
Table of contents
Overview
Poulvac E. coli is a vaccine that is used in chickens and turkeys for active immunisation against an infection caused by Escherichia coli serotype O78, called colibacillosis. Colibacillosis can cause injuries to the sac that surrounds the heart (pericarditis), the sac surrounding the liver (perihepatitis) and the ‘air sacs’, the specialised bags within the bird’s body where air is stored during breathing (airsacculitis), and can lead to death of the bird. The vaccine, which is for use in broiler chickens (reared for meat), future layers or breeders (reared for egg production) and turkeys, helps reduce injuries and deaths caused by the infection.
It contains the live bacteria Escherichia coli, type O78, strain EC34195 with a gene (aroA) deleted.
Authorisation details
Product details | |
---|---|
Name |
Poulvac E. coli
|
Agency product number |
EMEA/V/C/002007
|
Active substance |
Live aroA gene deleted Escherichia coli, type 078, strain EC34195
|
International non-proprietary name (INN) or common name |
Escherichia coli aroA gene deleted, type O78, strain EC34195 (live)
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI01AE04
|
Publication details | |
---|---|
Marketing-authorisation holder |
Zoetis Belgium SA
|
Revision |
10
|
Date of issue of marketing authorisation valid throughout the European Union |
15/06/2012
|
Contact address |
Rue Laid Burniat 1 |
Product information
09/09/2021 Poulvac E. coli - EMEA/V/C/002007 - II/0018
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for aves
-
Live bacterial vaccines
Therapeutic indication
For active immunisation of broiler chickens and future layers / breeders in order to reduce mortality and lesions (pericarditis, perihepatitis, airsacculitis) associated with Escherichia coli serotype O78.